SCI — AGM Information 2020

Sep 1, 2020

SCI Pharmtech, Inc. Meeting Notice For Annual Shareholders’ Meeting

(Summary Translation)

• I. The 2020 Annual Shareholders’ Meeting (the “Meeting”) of SCI Pharmtech, Inc. (the “Company”) will be held at No.55, Changrong Rd., Lu-Chu-District, Taoyuan City, Taiwan (Freedom Design hotel), at 9:00 a.m., June 19, 2020. The shareholders’ registration will begin at 8:30 a.m., and the place of registration is the same as the meeting location.

The agenda for the Meeting is as follows:

• (1)Report subjects:

1. Report on the compensation for employees and directors of 2019

2. Report on operating results of 2019

3. Report by Audit Committee on auditing of 2019 financial statements

4. Report on donation to related parties

5. Amendment to Rules of Procedure for Board of Directors Meetings

6. Amendment to Ethical Corporate Management Best Practice Principles

7. Amendment to Corporate Social Responsibility Best Practice Principles

(2)Recognition subjects:

1. Recognition of 2019 operation report and financial statements

2. Distribution of retained earnings

• (3)Election subjects:

N/A

• (4)Approval subjects:

1. Amendment to Rules of Procedure for Shareholders Meetings

2. Amendment to Regulation Governing Loaning of Funds

3. Amendment to Regulation Making of Endorsements/Guarantees

• II. Proposal for distribution of 2019 profits has been resolved by the Board of Directors as follows:

Cash dividends: Totaling NTD461,014,798, the proposed dividend in NTD5.8 per share.

• III. Pursuant to Article 165 of the Company Act, the Company hereby closes the share transfer registration from April 21, 2020 to June 19, 2020.

1

• IV. The shareholder’s voting power of this annual shareholders’ meeting may be exercised by way of electronic transmission, and the exercising period will be from May 20, 2020 through June 16, 2020. Please log in the homepage “shareholders vote by electronic way” established by Taiwan Depository & Clearing Corporation at https://www.stockvote.com.tw.

Board of Directors SCI Pharmtech, Inc.

2